Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase... (osium focused on therapeutic benefit f...)

Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results

Date:3/16/2009

osium, focused on therapeutic benefit from several novel agents that target key cellular systems involved in the progression of melanoma or other cutaneous diseases. This interactive symposium also emphasized issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients. Data was also presented on important clinical trials of novel therapeutic regimens in the adjuvant and advanced disease settings currently recruiting patients with melanoma and other cutaneous malignancies. In addition, the Intralesional Therapy for Melanoma: Two Steps Forward and One Step Back? Satellite Symposium, which included discussion on "Investigating Local Control Strategies: The Case for Intralesional Therapy-Emerging Approaches to Intralesional Therapy" focused on intralesional therapy as a strategy for both local and potentially systemic control of melanoma.

About Provectus Pharmaceuticals, Inc. (www.pvct.com)

Provectus Pharmaceuticals is a development stage company that specializes in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is currently conducting Phase 2 clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and atopic dermatitis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. The Company has received orphan drug designation from the FDA for its melanoma indication. Complementing their suite of proprietary drugs, Provectus has developed a number of intellectual properties and technologies in the areas of imaging, medical devices and biotechnology. For additional information about
'/>"/>

SOURCE Provectus Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost

Post Your Comments:

(Date:5/21/2013)... 21, 2013 Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...

(Date:5/21/2013)... NORTH BRUNSWICK, N.J. , May 21, 2013 /PRNewswire/ ... artificial tissue constructs and microfluidic cell-based assay platforms, today ... , PhD, DABT to the Company,s Board of ... of Preclinical Development of the Schering-Plough Research Institute ("SPRI"), ... prior to its acquisition by Merck & Co. in ...

(Date:5/21/2013)... YORK , May 21, 2013 /PRNewswire/ ... research report is available in its catalogue: ... Markets and Technologies for Optical Coherence Tomography ... STUDY OBJECTIVES ... this study is to offer synopsis of ...

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors [0] Global Markets and Technologies for Optical Coherence Tomography (OCT)

... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...

... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...

The Market for Prescription Dermatological Drugs, 7th Edition Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay ... life, but some of the changes brought about by ... diabetes. New research has found that people with ... percent higher risk of having a severe low blood ... compared to people with diabetes who aren,t depressed. ...

(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...

(Date:5/21/2013)... The team at Comfort &Harmony™, a leader in nurturing ... a nursing pillow. , Nursing pillows are designed ... , In a nursing pillow, important things to ... Designers at Comfort & Harmony, kept this list in mind ... pillow needs to fit a mom’s body and feel comfortable. ...

(Date:5/21/2013)... Texas (PRWEB) May 21, 2013 ... and process automation applications for video collaboration, today ... innovative vRating index evaluates key performance metrics related ... have an immediate, aggregated indicator of the performance ... of the Vyopta vAnalytics™ application, the vRating™ delivers ...

(Date:5/21/2013)... MAY 21, 2013 Three major Ohio universities and ... Foundation to establish a new collaborative research program aimed ... The March of Dimes intends to invest $10 million ... March of Dimes Prematurity Research Center -- Ohio Collaborative ... Howse, President of the March of Dimes. "This new ...

Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2 Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3 Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2 Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 2 Health News:Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow 3 Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 2 Health News:New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks 3 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 2 Health News:New multi-million dollar research center aims to solve the mystery of premature birth 3

[0] Depression May Raise Low Blood Sugar Risk in Diabetics [0] Mayo Clinic: How gold nanoparticles can help fight ovarian cancer [0] Comfort and Harmony™ Shares Tips on What to Look for in a Nursing Pillow [0] New vRating™ Video and Unified Communications Scoring System Delivers Innovative Approach to Measure Performance and ROI for Collaboration Networks [0] New multi-million dollar research center aims to solve the mystery of premature birth

... -- A new three-year study finds that a multiple sclerosis drug ... form of MS if it,s given early in patients who appear ... called "interferon beta-1a," is not available in the United States. It ... elsewhere. "While we,ve known it,s beneficial to start MS drugs ...

... have discovered that salicylate, the active ingredient in aspirin, ... protein kinase), a key player in regulating cell growth ... fuel-gauge is switched on by exercise and the commonly ... at McMaster University, the University of Dundee and the ...

... HealthDay Reporter , THURSDAY, April 19 (HealthDay News) -- ... the chronic inflammatory skin disease known as psoriasis than ... researchers found that biologics, which can cost upwards of ... standard drug treatment for psoriasis, methotrexate, but that their ...

... , THURSDAY, April 19 (HealthDay News) -- Most ... of a cancer diagnosis low: Don,t smoke, eat healthy, exercise ... make those choices, and a new report suggests that lawmakers ... those changes easier ones to make. ...

... , THURSDAY, April 19 (HealthDay News) -- Online ... a small new study. This is because scammers not ... them by pretending to have a meaningful connection with them. ... was a significant relationship. The U.K. study included 11 ...

... Scientists have identified 33 genes associated with autism and related ... to be altered in people with schizophrenia. Of the ... the first time, according to the study, which currently appears ... print issue of the journal Cell . "By ...

Cached Medicine News:Health News:Early Use of MS Drug May Cut Likelihood of Progression 2 Health News:McMaster researchers find potential for new uses of old drug 2 Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 2 Health News:New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds 3 Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 2 Health News:Healthy Lifestyle Choices Could Cut Cancer Rates: Report 3 Health News:Online Dating Scams Can Take Emotional, Financial Toll 2 Health News:Genes Associated With Autism Also Related to Schizophrenia 2

Early Use of MS Drug May Cut Likelihood of Progression McMaster researchers find potential for new uses of old drug New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds Healthy Lifestyle Choices Could Cut Cancer Rates: Report Online Dating Scams Can Take Emotional, Financial Toll Genes Associated With Autism Also Related to Schizophrenia

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Alanine Aminotransferase, Serum or Plasma ALA, Urine Al, Serum Ag (Silver), Urine